MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,04 report with the FDA on 2007-09-06 for CD 22 CONTROLS HALF PACK 99106-01 manufactured by Abbott Diagnostics Division/celldyn.
[718223]
The customer reported since using cell-dyn 22 platelet control lot 0125, the hemoglobin and platelet parameters are out of range. The customer opened a new medium level control and observed the same problem and further stated that the controls did not undergo any change in temperature. The customer received new controls which were all cloudy (hemolyzed) and had to assay the controls several times for the controls to be in range. The customer stated that the cell-dyn 22 controls are higher for pt hemoglobin compared to 2 other hematology instruments at the customer site. The customer requested a visit from abbott field service and technician adjusted the hemoglobin parameters to previous settings. Additionally, the customer received lot 0126 of the cell-dyn 22 controls and the performance of the new lot was acceptable. It is unk if there was impact to pt management.
Patient Sequence No: 1, Text Type: D, B5
[7813962]
Platelet recovery values were out of range high during stability testing for the cell-dyn 22 calibrators, lots 3099, 3098, and 3100 and cell-dyn 22 control lot 0125 for the cd3200 and/or cd ruby optical analyzers. Cell-dyn 22 calibrator lot 3098 did not meet shelf life stability on the cell-dyn 3200 analyzer at its expiry. Cell-dyn 22 calibrator lot 3099 did not meet shelf life stability and the 7 day open vial stability for the platelet parameter on the cell-dyn ruby analyzer. Internal data indicated that cell-dyn 22 calibrator lot 3100 was experiencing the same issues as it approached the october 6, 2006 expiry date. Cell-dyn 22 calibrators and controls are subjected to stability testing per abbott department operating procedures. The cell-dyn 22 calibrators and controls claim product shelf life and consecutive day open container stability. The calibrator and control values must meet the requirement within the published assay values and ranges per abbott stability testing parameters. The values recovered during stability testing are the same as product release values. An investigation was performed and probable causes were found to be a combination of the following issues: common cause process variability of the red blood cell fragmentation to platelet like particles affecting mean platelet volume, and special cause variation of tightening the platelet specification by 50%. It was determined that red blood cell fragmentation is enhanced by mechanical stress. These issues did not adequately predict an increase of platelet count through the established stability claims. The formulation and manufacturing process used in the manufacturing and testing of the cell-dyn 22 calibrators and controls are specific to both the calibrators and controls and does not impact the other instrument platforms, therefore, the identified probable cause is product specific. The corrective action for the cell-dyn 22 calibrators and controls is to re-evaluate the platelet specification, improve assay assignment procedure for platelet parameter, re-validate the platelet mfg process to increase the mean platelet volume and conduct monthly value assignment. This is the final report.
Patient Sequence No: 1, Text Type: N, H10
| Report Number | 2919069-2007-00137 |
| MDR Report Key | 907940 |
| Report Source | 01,04 |
| Date Received | 2007-09-06 |
| Date of Report | 2006-10-13 |
| Date of Event | 2006-06-30 |
| Date Mfgr Received | 2006-10-13 |
| Device Manufacturer Date | 2006-05-01 |
| Date Added to Maude | 2007-10-17 |
| Event Key | 0 |
| Report Source Code | Manufacturer report |
| Manufacturer Link | Y |
| Number of Patients in Event | 0 |
| Adverse Event Flag | 3 |
| Product Problem Flag | 3 |
| Reprocessed and Reused Flag | 3 |
| Health Professional | 3 |
| Initial Report to FDA | 3 |
| Report to FDA | 0 |
| Event Location | 0 |
| Manufacturer Contact | DR. DAVID BARCH, D-09Y6, AP6C-2 |
| Manufacturer Street | 100 ABBOTT PARK RD |
| Manufacturer City | ABBOTT PARK IL 600646092 |
| Manufacturer Country | US |
| Manufacturer Postal | 600646092 |
| Manufacturer Phone | 8479379328 |
| Single Use | 3 |
| Remedial Action | RC |
| Previous Use Code | 3 |
| Removal Correction Number | 2919069-9/26/06-003-C |
| Event Type | 3 |
| Type of Report | 3 |
| Brand Name | CD 22 CONTROLS HALF PACK |
| Generic Name | CD22 CONTROLS |
| Product Code | JCN |
| Date Received | 2007-09-06 |
| Model Number | NA |
| Catalog Number | 99106-01 |
| Lot Number | 0125 |
| ID Number | NA |
| Device Expiration Date | 2006-08-06 |
| Operator | OTHER |
| Device Availability | Y |
| Device Age | DA |
| Device Eval'ed by Mfgr | Y |
| Implant Flag | N |
| Date Removed | B |
| Device Sequence No | 1 |
| Device Event Key | 899498 |
| Manufacturer | ABBOTT DIAGNOSTICS DIVISION/CELLDYN |
| Manufacturer Address | 5440 PATRICK HENRY DR. SANTA CLARA CA 95054 US |
| Patient Number | Treatment | Outcome | Date |
|---|---|---|---|
| 1 | 0 | 2007-09-06 |